-
Some people have had trouble getting Paxlovid pills quickly, despite the administration's effort to ease access after a COVID test confirms infection.
-
Doctors have begun reporting cases of patients who see their symptoms return several days after treatment.
-
Data show that a third dose can help boost kids' immunity. Some experts are skeptical that another shot is needed for younger kids.
-
The antiviral pill is available to patients older than 12 who have tested positive for COVID and are at risk for developing a severe case of the disease.
-
The federal “test-to-treat” program was designed to be a one-stop shop for people to get tested and receive treatment. But as cases rise again, many communities have no participating locations, and website bugs make it difficult to book an appointment at the biggest participant.
-
The Food and Drug Administration has long warned against using the cow and horse dewormer to fight COVID-19, warning it can cause serious, adverse effects.
-
The new government website includes a locator tool for more than 2,000 sites to access "test to treat" services for COVID. It's meant to be a one-stop shop for Americans' pandemic needs.
-
The Biden administration has asked Congress to allocate $22.5 billion more for pandemic relief. But the funding is stalled and the effects are already being felt.
-
States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste while people who could benefit get sicker.
-
Even if you don't have long COVID, it can still take weeks to recover — much longer than the isolation period implies. Millions of Americans are finding that this still majorly disrupts their lives.
-
The White House asked for more money from Congress to keep its COVID response going. But that hasn't happened, so some things need to be wound down.
-
If you think you might have COVID-19 and are at high risk, you may be able to get tested at a clinic and treated with antiviral drugs right away, under the next phase of the pandemic plan.